You are here

  • Home
  • Archive
  • Volume 9, Issue 7
  • Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors

Article metrics

Article menu

Download PDFPDF

XML
Review
Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors

 

Online download statistics by month:

Online download statistics by month: July 2021 to July 2025

AbstractFullPdf
Jul 2021487490153
Aug 2021271272116
Sep 202121521574
Oct 202122022250
Nov 202119419444
Dec 202118719341
Jan 202222262232102
Feb 2022909232
Mar 2022889135
Apr 202215115632
May 202216617850
Jun 202221922038
Jul 202221821832
Aug 202223124030
Sep 202215616035
Oct 202217017749
Nov 2022616320
Dec 2022737423
Jan 2023919117
Feb 202328428514
Mar 2023515210
Apr 2023596020
May 202338388
Jun 202339409
Jul 2023494916
Aug 2023404011
Sep 2023555612
Oct 2023797914
Nov 2023797911
Dec 202310710811
Jan 2024262613
Feb 2024383813
Mar 2024323282
Apr 2024383817
May 2024333417
Jun 2024444418
Jul 2024515212
Aug 2024383710
Sep 2024343515
Oct 2024424212
Nov 2024252610
Dec 2024575811
Jan 2025383813
Feb 202521521548
Mar 2025393915
Apr 2025575712
May 2025191915
Jun 2025232323
Jul 2025110
Total724473181465